Evaluation of the effect of plant compounds extract (including aqueous extract of Ador-Cancer, saffron petals and mountain tea) in patients with coronary disease

Phase 2

Conditions: symptoms of COVID-19 patients.
COVID-19, virus identified
U07.1

Registration Number: IRCT20211108053002N1

Lead Sponsor: Rafsanjan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 40

Inclusion Criteria

Inclusion criteria in this study include all patients who have been diagnosed with Covid 19 infection and do not have other infections or diseases such as influenza, pulmonary insufficiency, ARDS pneumonia and other cold symptoms, as well as files with complete data. Consciously taken from patients.

Exclusion Criteria

Exclusion criteria included patients who had other infections or diseases such as influenza, pulmonary insufficiency, ARDS pneumonia and other cold symptoms and the result of Qovid 19 infection is negative. Also, files with incomplete data will be removed from this study. Obviously, conscious dissatisfaction also leads to exclusion from the study. Patients who were hospitalized and their clinical condition was deteriorating were excluded from the study and lung CT scans were obtained from patients. Patients with oxygen levels less than 93 mm Hg were excluded from the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The length of hospitalization of patients with Covid-19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record.;The mortality in patients with Covid-19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record.;The pulmonary infiltration in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: With CT scan.

Secondary Outcome Measures

Name	Time	Method
Side effects from the use of herbal compounds (COVID-herbs). Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Refer to the medical file and complete a special questionnaire for complications.;The liver function in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of SGOT and SGPT enzymes using ELISA kit.;The kidney function in patients with Covid-19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of chemical parameters such as BUN and Creatinine by colorimetric method with autoanalyzer.